Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
285
datasets available to search
ShareScore release 0.9.0
Dataset results
285 results for “regorafenib”
Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy
ClinicalTrials.gov study NCT03010722. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Evaluation - A Phase IIA Proof of Concept Study of Regorafenib (Bayer 73-4506) in Biopsy-amenable Asian Colorectal Cancer Patients
ClinicalTrials.gov study NCT01189903. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety and Pharmacokinetics of Regorafenib and Cetuximab in Combination
ClinicalTrials.gov study NCT01973868. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Regorafenib in Combination With TAS-102 in Subjects With Metastatic Colorectal Cancer Who Have Progressed After Standard Therapy
ClinicalTrials.gov study NCT03305913. IPD Sharing: NO. Countries: 1. Publications: 1.
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
ClinicalTrials.gov study NCT02259725. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers
ClinicalTrials.gov study NCT02241720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery
ClinicalTrials.gov study NCT02234180. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
ClinicalTrials.gov study NCT02098538. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment
ClinicalTrials.gov study NCT01853046. IPD Sharing: Not stated. Countries: 2. Publications: 0.
TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens
ClinicalTrials.gov study NCT06071052. IPD Sharing: NO. Countries: 1. Publications: 0.
FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer
ClinicalTrials.gov study NCT01913639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
ClinicalTrials.gov study NCT04704154. IPD Sharing: NO. Countries: 8. Publications: 0.
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer
ClinicalTrials.gov study NCT03992456. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy
ClinicalTrials.gov study NCT01538680. IPD Sharing: Not stated. Countries: 25. Publications: 2.
A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed
ClinicalTrials.gov study NCT03890731. IPD Sharing: NO. Countries: 5. Publications: 0.
A Phase 4 Study of Regorafenib in Metastatic Colorectal Cancer - Does Educating Physicians Change Patient Outcomes?
ClinicalTrials.gov study NCT02287025. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
ClinicalTrials.gov study NCT02080260. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
ClinicalTrials.gov study NCT02222207. IPD Sharing: Not stated. Countries: 18. Publications: 0.
Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma
ClinicalTrials.gov study NCT02048722. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib
ClinicalTrials.gov study NCT04327700. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.